
Drug shortage risk for Endo Pharmaceuticals after factory shut down
Endo Pharmaceuticals (NASDAQ:ENDP) faces a drug shortage risk for some of its opiates, such as Percocet, as Novartis Consumer Group sorts out a mix-up that could cause extended release opiates for Endo Pharmaceuticals to be bottled together with over-the-counter pain reliever Excedrin and stimulant NoDoz. The factory shutdown, though temporary, could cause a shortage for […]